Anemia Management in Chronic Kidney Disease

Diagnosis and Treatment

• The National Kidney Foundation recommends targeting a hemoglobin level of 110-120 g/L in patients with chronic kidney disease (CKD) 2, 3, 1
• The American Journal of Kidney Diseases suggests that a hemoglobin level below 110 g/L is associated with increased morbidity and mortality in CKD patients 2, 3, 1
• The Journal of Hepatology recommends checking serum B12 and folate levels in patients with macrocytosis and hypersegmented neutrophils 4, 5
• The American Journal of Kidney Diseases recommends verifying transferrin saturation ≥20% and ferritin ≥100 ng/mL before escalating erythropoiesis-stimulating agent (ESA) therapy 2, 6, 1

ESA Dosing and Monitoring

• The Praxis Medical Insights guidelines recommend increasing the ESA dose by 25-50% if hemoglobin increases <10 g/L after 4 weeks 1, 7
• The American Journal of Kidney Diseases suggests reducing the ESA dose by 25% if hemoglobin increases >30 g/L per month 1, 7
• The Kidney International journal recommends avoiding overcorrection of hemoglobin levels, as this can increase cardiovascular mortality and stroke risk 8

Iron Supplementation

• The American Journal of Kidney Diseases recommends intravenous iron supplementation for patients with CKD and iron deficiency 2, 6
• The Journal of Hepatology suggests that functional iron deficiency is a common cause of ESA hyporesponsiveness in CKD patients 4, 6, 1

Transfusion Threshold

• The Journal of Hepatology recommends a transfusion threshold of <70-75 g/L in stable CKD patients 4
• The Praxis Medical Insights guidelines suggest considering transfusion if the patient is symptomatic at a hemoglobin level of 104 g/L 4, 7